{"dataset":"ctas","license":{"id":"CC-BY-4.0","name":"Creative Commons Attribution 4.0 International","url":"https://creativecommons.org/licenses/by/4.0/","cite":"optimism.fun"},"updated":"2026-11-20","count":131,"rows":[{"id":"securebio-build-biosecurity","kind":"build","type":"nonprofit","name":"SecureBio","url":"https://securebio.org","one_liner":"Builds pandemic early-warning and AI-biosecurity defenses, including DNA synthesis screening research.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"nucleic-acid-observatory-now-securebio-early-detection-build-biosecurity","kind":"build","type":"nonprofit","name":"Nucleic Acid Observatory (now SecureBio Early Detection)","url":"https://securebio.org/detection/","one_liner":"Runs metagenomic sequencing of wastewater and air to detect novel or engineered pathogens early.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"blueprint-biosecurity-build-biosecurity","kind":"build","type":"nonprofit","name":"Blueprint Biosecurity","url":"https://blueprintbiosecurity.org","one_liner":"Develops roadmaps and projects for far-UVC, next-generation PPE, and other pandemic-proofing technologies.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"ibbis-international-biosecurity-and-biosafety-initiative-for-science-build-biosecurity","kind":"build","type":"nonprofit","name":"IBBIS (International Biosecurity and Biosafety Initiative for Science)","url":"https://ibbis.bio","one_liner":"Develops the open Common Mechanism tool and standards for screening DNA synthesis orders.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"securedna-build-biosecurity","kind":"build","type":"nonprofit","name":"SecureDNA","url":"https://securedna.org","one_liner":"Offers free, privacy-preserving cryptographic screening of DNA synthesis orders for hazardous sequences.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"biobot-analytics-build-biosecurity","kind":"build","type":"startup","name":"Biobot Analytics","url":"https://biobot.io","one_liner":"Turns wastewater sampling into community-level pathogen surveillance data.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"US","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"far-uv-technologies-build-biosecurity","kind":"build","type":"startup","name":"Far UV Technologies","url":"https://faruv.com","one_liner":"Makes far-UVC lamps intended to inactivate airborne pathogens in occupied rooms.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"johns-hopkins-center-for-health-security-build-biosecurity","kind":"build","type":"nonprofit","name":"Johns Hopkins Center for Health Security","url":"https://centerforhealthsecurity.org","one_liner":"Researches and advises governments on preventing and responding to pandemics and biological threats.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":false,"license":"CC-BY-4.0"},{"id":"cepi-coalition-for-epidemic-preparedness-innovations-fund-biosecurity","kind":"fund","type":"fund","name":"CEPI (Coalition for Epidemic Preparedness Innovations)","url":"https://cepi.net","one_liner":"Funds vaccine R&D toward the 100 Days Mission of a safe vaccine within 100 days of a new outbreak.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"the-pandemic-fund-fund-biosecurity","kind":"fund","type":"grant","name":"The Pandemic Fund","url":"https://www.thepandemicfund.org","one_liner":"Gives grants to low- and middle-income countries to strengthen disease surveillance, labs, and workforce.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":false,"license":"CC-BY-4.0"},{"id":"coefficient-giving-formerly-open-philanthropy-biosecurity-and-pandemic-p-fund-biosecurity","kind":"fund","type":"fund","name":"Coefficient Giving (formerly Open Philanthropy), Biosecurity and Pandemic Preparedness","url":"https://coefficientgiving.org/funds/biosecurity-pandemic-preparedness/","one_liner":"Makes large philanthropic grants to reduce global catastrophic biological risks.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"longview-philanthropy-fund-biosecurity","kind":"fund","type":"fund","name":"Longview Philanthropy","url":"https://www.longview.org","one_liner":"Advises and pools donors to fund work on catastrophic biological and AI risks.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"survival-and-flourishing-fund-fund-biosecurity","kind":"fund","type":"grant","name":"Survival and Flourishing Fund","url":"https://survivalandflourishing.fund","one_liner":"Runs recurring grant rounds for organizations working on existential risks, including biosecurity.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"About $216 million in gifts and grants organized since 2019 (all cause areas)","amount_source_url":"https://survivalandflourishing.fund","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"barda-drive-fund-biosecurity","kind":"fund","type":"grant","name":"BARDA DRIVe","url":"https://drive.hhs.gov","one_liner":"US government program that funds early-stage health security technologies and startups.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"US","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":false,"license":"CC-BY-4.0"},{"id":"ushio-care222-far-uvc-buy-biosecurity","kind":"buy","type":"product","name":"Ushio Care222 far-UVC","url":"https://www.ushio.com/product/care222-filtered-far-uv-c-excimer-lamp-module/","one_liner":"Commercial far-UVC lamp modules for disinfecting air in occupied indoor spaces.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"far-uv-technologies-krypton-lamps-buy-biosecurity","kind":"buy","type":"product","name":"Far UV Technologies Krypton lamps","url":"https://faruv.com","one_liner":"Ready-to-install far-UVC fixtures for offices, clinics, and schools.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"vaccines-gov-buy-biosecurity","kind":"buy","type":"product","name":"Vaccines.gov","url":"https://www.vaccines.gov","one_liner":"Finds nearby flu, COVID-19 and other vaccines (US-only).","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"US only","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"80-000-hours-preventing-catastrophic-pandemics-learn-biosecurity","kind":"learn","type":"report","name":"80,000 Hours: Preventing catastrophic pandemics","url":"https://80000hours.org/problem-profiles/preventing-catastrophic-pandemics/","one_liner":"Explains why engineered pandemics are a top global risk and which careers help.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"100-days-mission-international-pandemic-preparedness-secretariat-learn-biosecurity","kind":"learn","type":"report","name":"100 Days Mission (International Pandemic Preparedness Secretariat)","url":"https://ippsecretariat.org","one_liner":"Tracks progress toward vaccines, tests and treatments within 100 days of a pandemic threat.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"blueprint-biosecurity-far-uvc-program-learn-biosecurity","kind":"learn","type":"report","name":"Blueprint Biosecurity: Far-UVC program","url":"https://blueprintbiosecurity.org/program/far-uvc/","one_liner":"Lays out the research and deployment roadmap for making far-UVC a safe, widespread pandemic defense.","problem_slugs":"biosecurity|infectious-disease","risk_slugs":"engineered-pandemics","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"openaq-build-copd","kind":"build","type":"nonprofit","name":"OpenAQ","url":"https://openaq.org","one_liner":"Aggregates and publishes open air quality data from governments and sensors worldwide.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"clean-cooking-alliance-build-copd","kind":"build","type":"nonprofit","name":"Clean Cooking Alliance","url":"https://cleancooking.org","one_liner":"Works to expand clean cooking to end household air pollution from solid fuels.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"airqo-makerere-university-build-copd","kind":"build","type":"nonprofit","name":"AirQo (Makerere University)","url":"https://airqo.net","one_liner":"Deploys low-cost air quality sensor networks and data across African cities.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"Uganda / Africa","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"clarity-movement-build-copd","kind":"build","type":"startup","name":"Clarity Movement","url":"https://www.clarity.io","one_liner":"Sells air quality monitoring networks used by cities and researchers.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"burn-manufacturing-build-copd","kind":"build","type":"startup","name":"BURN Manufacturing","url":"https://burnstoves.com","one_liner":"Manufactures efficient cookstoves for Africa, cutting smoke and charcoal use.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"Kenya / Africa","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"vital-strategies-air-quality-build-copd","kind":"build","type":"nonprofit","name":"Vital Strategies, Air Quality","url":"https://www.vitalstrategies.org","one_liner":"Helps city and national governments measure air pollution and adopt clean air policies.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"energy-policy-institute-at-uchicago-aqli-build-copd","kind":"build","type":"nonprofit","name":"Energy Policy Institute at UChicago (AQLI)","url":"https://aqli.epic.uchicago.edu","one_liner":"Translates particulate pollution into lost life expectancy to guide policy.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"clean-air-fund-fund-copd","kind":"fund","type":"fund","name":"Clean Air Fund","url":"https://www.cleanairfund.org","one_liner":"Global philanthropy that funds and coordinates work to cut air pollution.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"climate-and-clean-air-coalition-fund-copd","kind":"fund","type":"grant","name":"Climate and Clean Air Coalition","url":"https://www.ccacoalition.org","one_liner":"UNEP-hosted partnership that funds action on short-lived climate pollutants like black carbon and methane.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":false,"license":"CC-BY-4.0"},{"id":"bloomberg-philanthropies-fund-copd","kind":"fund","type":"fund","name":"Bloomberg Philanthropies","url":"https://www.bloomberg.org","one_liner":"Funds clean air and clean energy campaigns, including city air quality programs.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":false,"license":"CC-BY-4.0"},{"id":"coefficient-giving-formerly-open-philanthropy-air-quality-fund-fund-copd","kind":"fund","type":"fund","name":"Coefficient Giving (formerly Open Philanthropy), Air Quality fund","url":"https://coefficientgiving.org/funds/air-quality/","one_liner":"Philanthropic fund for reducing outdoor air pollution, with a focus on South Asia.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"us-epa-air-grants-and-funding-fund-copd","kind":"fund","type":"grant","name":"US EPA Air Grants and Funding","url":"https://www.epa.gov/grants/air-grants-and-funding","one_liner":"Lists federal grants for air monitoring and emissions reduction (US-only).","problem_slugs":"copd|climate-change","risk_slugs":"","location":"US only","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"purpleair-buy-copd","kind":"buy","type":"product","name":"PurpleAir","url":"https://www2.purpleair.com","one_liner":"Low-cost air quality sensors that feed a public real-time PM2.5 map.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"smart-air-buy-copd","kind":"buy","type":"product","name":"Smart Air","url":"https://smartairfilters.com","one_liner":"Social enterprise selling low-cost, tested air purifiers and masks.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"iqair-buy-copd","kind":"buy","type":"product","name":"IQAir","url":"https://www.iqair.com","one_liner":"Air purifiers, monitors and a free app with global real-time air quality data.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":false,"license":"CC-BY-4.0"},{"id":"aqli-reports-archive-air-quality-life-index-learn-copd","kind":"learn","type":"report","name":"AQLI reports archive (Air Quality Life Index)","url":"https://aqli.epic.uchicago.edu/dataInsights/archive?filter=report","one_liner":"Annual report on how much life expectancy particulate pollution costs each country.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"state-of-global-air-learn-copd","kind":"learn","type":"report","name":"State of Global Air","url":"https://www.stateofglobalair.org","one_liner":"HEI and IHME report on global exposure to and health burden of air pollution.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"who-global-air-quality-guidelines-2021-learn-copd","kind":"learn","type":"report","name":"WHO Global Air Quality Guidelines (2021)","url":"https://www.who.int/publications/i/item/9789240034228","one_liner":"Sets the health-based limits for PM2.5, ozone, NO2 and other pollutants.","problem_slugs":"copd|climate-change","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"givedirectly-build-extreme-poverty","kind":"build","type":"nonprofit","name":"GiveDirectly","url":"https://www.givedirectly.org","one_liner":"Sends unconditional cash transfers directly to people living in extreme poverty.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"one-acre-fund-build-extreme-poverty","kind":"build","type":"nonprofit","name":"One Acre Fund","url":"https://oneacrefund.org","one_liner":"Supplies smallholder farmers in Africa with inputs, financing and training to raise incomes.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"Africa","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"brac-ultra-poor-graduation-build-extreme-poverty","kind":"build","type":"nonprofit","name":"BRAC Ultra-Poor Graduation","url":"https://www.brac.net/solutions/development/ending-poverty/ultra-poor-graduation/","one_liner":"Scales the graduation approach that moves ultra-poor households into sustainable livelihoods.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"village-enterprise-build-extreme-poverty","kind":"build","type":"nonprofit","name":"Village Enterprise","url":"https://villageenterprise.org","one_liner":"Funds and trains groups of people in extreme poverty to start small businesses in East Africa.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"East Africa","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"evidence-action-build-extreme-poverty","kind":"build","type":"nonprofit","name":"Evidence Action","url":"https://www.evidenceaction.org","one_liner":"Scales cost-effective, evidence-backed programs like safe water and deworming.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"m-kopa-build-extreme-poverty","kind":"build","type":"startup","name":"M-KOPA","url":"https://www.m-kopa.com","one_liner":"Offers pay-as-you-go financing for smartphones, solar and other assets to underbanked customers in Africa.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"Africa","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"wave-build-extreme-poverty","kind":"build","type":"startup","name":"Wave","url":"https://www.wave.com","one_liner":"Low-fee mobile money service in West Africa.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"West Africa","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"apollo-agriculture-build-extreme-poverty","kind":"build","type":"startup","name":"Apollo Agriculture","url":"https://www.apolloagriculture.com","one_liner":"Gives smallholder farmers in Kenya and Zambia credit, inputs and advice.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"Kenya, Zambia","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"givewell-fund-extreme-poverty","kind":"fund","type":"fund","name":"GiveWell","url":"https://www.givewell.org","one_liner":"Researches and funds the most cost-effective charities for people in low-income countries.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"global-innovation-fund-fund-extreme-poverty","kind":"fund","type":"fund","name":"Global Innovation Fund","url":"https://www.globalinnovation.fund","one_liner":"Invests grants, loans and equity in innovations that improve the lives of people in poverty.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"mulago-foundation-fund-extreme-poverty","kind":"fund","type":"fund","name":"Mulago Foundation","url":"https://www.mulagofoundation.org","one_liner":"Philanthropic venture fund backing scalable organizations that give the very poor a route out of poverty.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"the-life-you-can-save-fund-extreme-poverty","kind":"fund","type":"fund","name":"The Life You Can Save","url":"https://www.thelifeyoucansave.org","one_liner":"Recommends and pools donations for vetted charities fighting extreme poverty.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"founders-pledge-ghd-catalytic-impact-fund-fund-extreme-poverty","kind":"fund","type":"fund","name":"Founders Pledge GHD Catalytic Impact Fund","url":"https://www.founderspledge.com/programs/ghd-catalytic-impact-fund","one_liner":"Pooled fund targeting high-leverage global health and poverty grants.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"gates-foundation-fund-extreme-poverty","kind":"fund","type":"fund","name":"Gates Foundation","url":"https://www.gatesfoundation.org","one_liner":"Largest private funder of global health and development programs.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"donate-to-givedirectly-buy-extreme-poverty","kind":"buy","type":"product","name":"Donate to GiveDirectly","url":"https://www.givedirectly.org/give-now/","one_liner":"Send cash directly to a household in extreme poverty.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"kiva-buy-extreme-poverty","kind":"buy","type":"product","name":"Kiva","url":"https://www.kiva.org","one_liner":"Lend small amounts to entrepreneurs in low-income countries.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"givewell-top-charities-fund-buy-extreme-poverty","kind":"buy","type":"product","name":"GiveWell Top Charities Fund","url":"https://www.givewell.org/top-charities-fund","one_liner":"Donate to GiveWell top charities, allocated where most needed.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"our-world-in-data-poverty-learn-extreme-poverty","kind":"learn","type":"report","name":"Our World in Data: Poverty","url":"https://ourworldindata.org/poverty","one_liner":"Charts and explains how extreme poverty is measured and how it has changed.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"world-bank-poverty-prosperity-and-planet-report-2024-learn-extreme-poverty","kind":"learn","type":"report","name":"World Bank: Poverty, Prosperity, and Planet Report 2024","url":"https://www.worldbank.org/en/publication/poverty-prosperity-and-planet","one_liner":"The World Bank flagship assessment of global poverty trends.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"j-pal-building-stable-livelihoods-for-low-income-households-learn-extreme-poverty","kind":"learn","type":"report","name":"J-PAL: Building stable livelihoods for low-income households","url":"https://www.povertyactionlab.org/policy-insight/building-stable-livelihoods-low-income-households","one_liner":"Summarizes randomized evidence on the graduation approach.","problem_slugs":"extreme-poverty","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"altos-labs-build-longevity","kind":"build","type":"startup","name":"Altos Labs","url":"https://altoslabs.com","one_liner":"Researches cellular rejuvenation programming to reverse disease and aging.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"retro-biosciences-build-longevity","kind":"build","type":"startup","name":"Retro Biosciences","url":"https://retro.bio","one_liner":"Develops therapies aimed at adding healthy years via cellular reprogramming, autophagy and blood replacement.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"newlimit-build-longevity","kind":"build","type":"startup","name":"NewLimit","url":"https://www.newlimit.com","one_liner":"Uses epigenetic reprogramming to restore youthful function to cells.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"calico-build-longevity","kind":"build","type":"startup","name":"Calico","url":"https://www.calicolabs.com","one_liner":"Alphabet-founded company researching the biology of aging.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"loyal-build-longevity","kind":"build","type":"startup","name":"Loyal","url":"https://loyal.com","one_liner":"Developing drugs to extend healthy lifespan in dogs.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"bioage-labs-build-longevity","kind":"build","type":"startup","name":"BioAge Labs","url":"https://bioagelabs.com","one_liner":"Develops therapies for metabolic diseases of aging using human aging data.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"buck-institute-for-research-on-aging-build-longevity","kind":"build","type":"nonprofit","name":"Buck Institute for Research on Aging","url":"https://www.buckinstitute.org","one_liner":"Independent research institute dedicated to the biology of aging.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"xprize-healthspan-fund-longevity","kind":"fund","type":"prize","name":"XPRIZE Healthspan","url":"https://www.xprize.org/competitions/healthspan","one_liner":"Prize competition for therapies that restore muscle, cognitive and immune function in older adults.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"$101 million prize purse (2023 to 2030)","amount_source_url":"https://www.xprize.org/competitions/healthspan","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"hevolution-foundation-fund-longevity","kind":"fund","type":"fund","name":"Hevolution Foundation","url":"https://hevolution.com","one_liner":"Funds aging biology research and healthspan-extending science.","problem_slugs":"longevity","risk_slugs":"","location":"Riyadh, Saudi Arabia","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"impetus-grants-norn-group-fund-longevity","kind":"fund","type":"grant","name":"Impetus Grants (Norn Group)","url":"https://norn.group/impetus-grants","one_liner":"Fast grants for speculative, early-stage longevity research.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"american-federation-for-aging-research-fund-longevity","kind":"fund","type":"grant","name":"American Federation for Aging Research","url":"https://www.afar.org","one_liner":"Funds early-career scientists studying aging biology.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"national-institute-on-aging-fund-longevity","kind":"fund","type":"grant","name":"National Institute on Aging","url":"https://www.nia.nih.gov","one_liner":"US federal funder of aging research (US-based, but funds international researchers in some programs).","problem_slugs":"longevity","risk_slugs":"","location":"US","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"age1-fund-longevity","kind":"fund","type":"fund","name":"age1","url":"https://www.age1.com","one_liner":"Venture fund investing in longevity biotech startups.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"vitadao-buy-longevity","kind":"buy","type":"product","name":"VitaDAO","url":"https://www.vitadao.com","one_liner":"Community-governed collective that funds longevity research and lets members back projects.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"lev-foundation-buy-longevity","kind":"buy","type":"product","name":"LEV Foundation","url":"https://www.levf.org","one_liner":"Donate to robust mouse rejuvenation studies that combine multiple aging interventions.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"function-health-buy-longevity","kind":"buy","type":"product","name":"Function Health","url":"https://www.functionhealth.com","one_liner":"Paid membership for extensive lab testing to track health markers (US-only).","problem_slugs":"longevity","risk_slugs":"","location":"US only","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"hallmarks-of-aging-an-expanding-universe-cell-2023-learn-longevity","kind":"learn","type":"paper","name":"Hallmarks of aging: An expanding universe (Cell, 2023)","url":"https://doi.org/10.1016/j.cell.2022.11.001","one_liner":"The standard framework of 12 biological hallmarks that drive aging.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"laura-deming-longevity-faq-learn-longevity","kind":"learn","type":"report","name":"Laura Deming: Longevity FAQ","url":"https://www.ldeming.com/longevityfaq","one_liner":"Beginner-friendly guide to the science and field of aging research.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"aging-biotech-info-learn-longevity","kind":"learn","type":"report","name":"Aging Biotech Info","url":"https://agingbiotech.info","one_liner":"Tracks companies, clinical trials and funding in aging biotech.","problem_slugs":"longevity","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"redwood-research-build-ai-control","kind":"build","type":"nonprofit","name":"Redwood Research","url":"https://www.redwoodresearch.org","one_liner":"Pioneered AI control research on keeping possibly misaligned AI systems safe.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"metr-build-ai-control","kind":"build","type":"nonprofit","name":"METR","url":"https://metr.org","one_liner":"Evaluates frontier AI models for dangerous autonomous capabilities.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"apollo-research-build-ai-control","kind":"build","type":"nonprofit","name":"Apollo Research","url":"https://www.apolloresearch.ai","one_liner":"Researches and evaluates deceptive behavior and scheming in AI systems.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"uk-ai-security-institute-build-ai-control","kind":"build","type":"government","name":"UK AI Security Institute","url":"https://www.aisi.gov.uk","one_liner":"UK government institute testing frontier AI and funding alignment and control research.","problem_slugs":"","risk_slugs":"ai-control","location":"UK","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"far-ai-build-ai-control","kind":"build","type":"nonprofit","name":"FAR.AI","url":"https://far.ai","one_liner":"Runs AI safety research and field-building events.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"goodfire-build-ai-control","kind":"build","type":"startup","name":"Goodfire","url":"https://www.goodfire.ai","one_liner":"Builds interpretability tools for understanding and editing neural networks.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"transluce-build-ai-control","kind":"build","type":"nonprofit","name":"Transluce","url":"https://transluce.org","one_liner":"Builds open tools for understanding and overseeing AI systems.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"mats-build-ai-control","kind":"build","type":"nonprofit","name":"MATS","url":"https://www.matsprogram.org","one_liner":"Research mentorship program that trains new AI alignment researchers.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"coefficient-giving-navigating-transformative-ai-fund-ai-control","kind":"fund","type":"fund","name":"Coefficient Giving (formerly Open Philanthropy), Navigating Transformative AI","url":"https://coefficientgiving.org/funds/navigating-transformative-ai/","one_liner":"Largest philanthropic funder of technical AI safety research.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"ea-funds-transformative-ai-fund-fund-ai-control","kind":"fund","type":"grant","name":"EA Funds Transformative AI Fund","url":"https://funds.effectivealtruism.org/funds/transformative-ai","one_liner":"Successor to the closed Long-Term Future Fund; grants to people and projects working to make transformative AI go well.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"survival-and-flourishing-fund-fund-ai-control","kind":"fund","type":"grant","name":"Survival and Flourishing Fund","url":"https://survivalandflourishing.fund","one_liner":"Recurring grant rounds for organizations working on AI safety and other existential risks.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"About $216 million in gifts and grants organized since 2019 (all cause areas)","amount_source_url":"https://survivalandflourishing.fund","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"the-alignment-project-uk-aisi-fund-ai-control","kind":"fund","type":"grant","name":"The Alignment Project (UK AISI)","url":"https://alignmentproject.aisi.gov.uk","one_liner":"Funds research on AI alignment and control, with compute support.","problem_slugs":"","risk_slugs":"ai-control","location":"UK-led, international applicants","amount":"Grants of up to £1 million per project; over £27 million awarded to 60+ projects in the first round","amount_source_url":"https://alignmentproject.aisi.gov.uk","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"schmidt-sciences-science-of-trustworthy-ai-fund-ai-control","kind":"fund","type":"grant","name":"Schmidt Sciences: Science of Trustworthy AI","url":"https://www.schmidtsciences.org/trustworthy-ai/","one_liner":"Funds foundational research on the science of making AI safe and trustworthy.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"manifund-fund-ai-control","kind":"fund","type":"fund","name":"Manifund","url":"https://manifund.org","one_liner":"Regranting platform where donors and regrantors fund AI safety projects.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"bluedot-impact-courses-buy-ai-control","kind":"buy","type":"product","name":"BlueDot Impact courses","url":"https://bluedot.org","one_liner":"Free online courses on AI safety and governance.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"donate-via-manifund-buy-ai-control","kind":"buy","type":"product","name":"Donate via Manifund","url":"https://manifund.org/projects","one_liner":"Back individual AI safety projects directly.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"ai-control-improving-safety-despite-intentional-subversion-learn-ai-control","kind":"learn","type":"paper","name":"AI Control: Improving Safety Despite Intentional Subversion","url":"https://arxiv.org/abs/2312.06942","one_liner":"The Redwood Research paper that defined the AI control agenda.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"international-ai-safety-report-learn-ai-control","kind":"learn","type":"report","name":"International AI Safety Report","url":"https://internationalaisafetyreport.org","one_liner":"Independent scientific assessment of general-purpose AI risks, chaired by Yoshua Bengio.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"80-000-hours-loss-of-control-problem-profile-learn-ai-control","kind":"learn","type":"report","name":"80,000 Hours: Loss of control (problem profile)","url":"https://80000hours.org/problem-profiles/loss-of-control/","one_liner":"Explains why misaligned AI could be catastrophic and what work helps.","problem_slugs":"","risk_slugs":"ai-control","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-01","checked":true,"license":"CC-BY-4.0"},{"id":"revolution-medicines-daraxonrasib-build-cancer","kind":"build","type":"startup","name":"Revolution Medicines","url":"https://www.fda.gov/drugs/cancer-approvals/fda-approves-daraxonrasib-metastatic-pancreatic-adenocarcinoma","one_liner":"FDA approved daraxonrasib (RASONQUE) on 26 August 2026 for metastatic pancreatic adenocarcinoma after prior therapy, or when multiagent therapy is not an option.","problem_slugs":"cancer","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"rasonque-daraxonrasib-buy-cancer","kind":"buy","type":"product","name":"RASONQUE (daraxonrasib)","url":"https://www.fda.gov/drugs/cancer-approvals/fda-approves-daraxonrasib-metastatic-pancreatic-adenocarcinoma","one_liner":"A once-daily oral RAS inhibitor. The FDA approved it on 26 August 2026 for metastatic pancreatic adenocarcinoma.","problem_slugs":"cancer","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"cancer-grand-challenges-fund-cancer","kind":"fund","type":"grant","name":"Cancer Grand Challenges","url":"https://cancergrandchallenges.org","one_liner":"Funds global teams to take on cancer research challenges it sets. Founded by Cancer Research and the National Cancer Institute.","problem_slugs":"cancer","risk_slugs":"","location":"","amount":"up to $34m","amount_source_url":"https://cancergrandchallenges.org","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"interpath-001-intismeran-learn-cancer","kind":"learn","type":"paper","name":"INTerpath-001","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa2609762","one_liner":"Phase 3 trial of intismeran autogene plus pembrolizumab after surgery for high-risk melanoma. NEJM, 11 November 2026. DOI 10.1056/NEJMoa2609762.","problem_slugs":"cancer","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"nhs-galleri-learn-cancer","kind":"learn","type":"paper","name":"NHS-Galleri","url":"https://ascopubs.org/doi/10.1200/JCO.2026.44.17_suppl.LBA100","one_liner":"Randomised trial of the Galleri blood test added to NHS screening. The primary late-stage endpoint was not met (incidence rate ratio 1.03).","problem_slugs":"cancer","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"masai-ai-mammography-learn-cancer","kind":"learn","type":"paper","name":"MASAI","url":"https://doi.org/10.1016/S0140-6736(25)02464-X","one_liner":"Swedish randomised trial of AI support in mammography. Interval cancers were non-inferior to standard double reading, with higher sensitivity. The Lancet, 2026.","problem_slugs":"cancer","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"nci-genomic-data-commons-learn-cancer","kind":"learn","type":"government","name":"NCI Genomic Data Commons","url":"https://gdc.cancer.gov/","one_liner":"NCI repository and analysis platform for cancer genome programs, including The Cancer Genome Atlas.","problem_slugs":"cancer","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"tcga-learn-cancer","kind":"learn","type":"government","name":"The Cancer Genome Atlas","url":"https://www.cancer.gov/ccg/research/genome-sequencing/tcga","one_liner":"NCI and NHGRI program that molecularly characterized over 20,000 primary cancers across 33 types. The data remains public.","problem_slugs":"cancer","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"uk-biobank-learn-cancer","kind":"learn","type":"nonprofit","name":"UK Biobank","url":"https://www.ukbiobank.ac.uk/","one_liner":"Follows 500,000 volunteers so approved researchers can study who falls ill and why.","problem_slugs":"cancer","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"verve-102-pcsk9-learn-heart-disease","kind":"learn","type":"paper","name":"VERVE-102","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa2601283","one_liner":"Phase 1 study of VERVE-102, a base-editing therapy designed to inactivate PCSK9 in the liver. NEJM, 2026.","problem_slugs":"heart-disease","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"ctx310-angptl3-learn-heart-disease","kind":"learn","type":"paper","name":"CTX310","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa2511778","one_liner":"Phase 1 trial of CTX310, a CRISPR-Cas9 editor aimed at hepatic ANGPTL3. NEJM, 2025.","problem_slugs":"heart-disease","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"select-semaglutide-learn-heart-disease","kind":"learn","type":"paper","name":"SELECT","url":"https://www.nejm.org/doi/full/10.1056/nejmoa2307563","one_liner":"Weekly semaglutide reduced major cardiovascular events versus placebo in people with cardiovascular disease and overweight or obesity, without diabetes. Hazard ratio 0.80.","problem_slugs":"heart-disease","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"vesalius-cv-evolocumab-learn-heart-disease","kind":"learn","type":"paper","name":"VESALIUS-CV","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa2514428","one_liner":"Evolocumab in people without a prior myocardial infarction or stroke. The primary 3-point MACE hazard ratio was 0.75.","problem_slugs":"heart-disease","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"lpa-horizon-pelacarsen-learn-heart-disease","kind":"learn","type":"paper","name":"Lp(a)HORIZON","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa2610159","one_liner":"Pelacarsen lowered lipoprotein(a) and did not reduce major cardiovascular events. Hazard ratio 1.02.","problem_slugs":"heart-disease","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"zeus-ziltivekimab-learn-heart-disease","kind":"learn","type":"paper","name":"ZEUS","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa2612126","one_liner":"Ziltivekimab lowered interleukin-6 and did not reduce cardiovascular events versus placebo. Hazard ratio 0.99.","problem_slugs":"heart-disease","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"cleerly-labs-build-heart-disease","kind":"build","type":"startup","name":"Cleerly","url":"https://cleerly.com/press/fda-clearance-cleerly-labs","one_liner":"Builds FDA-cleared software that reads coronary plaque and stenosis from CT. An updated Cleerly LABS was cleared on 30 October 2026.","problem_slugs":"heart-disease","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"cleerly-labs-buy-heart-disease","kind":"buy","type":"product","name":"Cleerly LABS","url":"https://cleerly.com/press/fda-clearance-cleerly-labs","one_liner":"Coronary CT analysis software. The FDA cleared an updated version, including the PLAQUE algorithm, on 30 October 2026.","problem_slugs":"heart-disease","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"cuorips-ipsc-sheets-build-heart-disease","kind":"build","type":"startup","name":"Cuorips","url":"https://www.cuorips.co.jp/news-en/20260306","one_liner":"Japan conditionally approved its iPSC-derived cardiomyocyte sheet on 6 March 2026 for severe ischemic heart failure.","problem_slugs":"heart-disease","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"who-ghe-deaths-learn-heart-disease","kind":"learn","type":"government","name":"WHO Global Health Estimates","url":"https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death/","one_liner":"Downloadable death counts by cause, age, and sex for 2000 through 2023, from Global Health Estimates 2023.","problem_slugs":"heart-disease","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"until-rewarming-build-organ-banking","kind":"build","type":"startup","name":"Until","url":"https://www.untillabs.com/blog/rewarming","one_liner":"Until reports that its Mark 1 rewarmed a vitrified pig kidney, at 59 degrees per minute in a deep vein and 73 degrees per minute in the cortex.","problem_slugs":"organ-banking","risk_slugs":"","location":"United States","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"until-roadmap-learn-organ-banking","kind":"learn","type":"report","name":"Until roadmap","url":"https://www.untillabs.com/roadmap","one_liner":"Until says it is developing reversible cryopreservation for human organs, and lists a first-in-human organ trial as future work.","problem_slugs":"organ-banking","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"srtr-2024-nonuse-learn-organ-banking","kind":"learn","type":"government","name":"OPTN/SRTR 2024 deceased donation report","url":"https://srtr.hrsa.gov/adr/2024/DOD/","one_liner":"The report says 11,244 organs were recovered for transplant in 2024 and not transplanted, 20.7 percent of organs recovered.","problem_slugs":"organ-banking","risk_slugs":"","location":"United States","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"hrsa-waitlist-learn-organ-shortage","kind":"learn","type":"government","name":"HRSA organ donation statistics","url":"https://www.organdonor.gov/learn/organ-donation-statistics","one_liner":"Reviewed August 2026: 109,817 people are on the US transplant waiting list, and 12 people die each day waiting.","problem_slugs":"organ-shortage|organ-banking","risk_slugs":"","location":"United States","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"egenesis-egen-2784-build-organ-shortage","kind":"build","type":"startup","name":"eGenesis","url":"https://egenesisbio.com/news-media/press-releases/egenesis-announces-clinical-update-in-ongoing-expanded-access-study-of-egen-2784-in-patients-with-kidney-failure","one_liner":"eGenesis says five patients received an EGEN-2784 pig kidney under expanded access since March 2024, and expects a Phase 1/2/3 trial to start in the first quarter of 2027.","problem_slugs":"organ-shortage","risk_slugs":"","location":"Cambridge, Massachusetts","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"godt-2024-learn-organ-shortage","kind":"learn","type":"report","name":"WHO Global Observatory on Donation and Transplantation, 2024","url":"https://www.transplant-observatory.org/wp-content/uploads/2026/03/glostatpubTransplantation.pdf","one_liner":"91 countries reported 173,727 solid organ transplants for 2024, a 2 percent increase from 2023. The report says the organ shortage continues.","problem_slugs":"organ-shortage","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"neuralink-gb-prime-build-brain-computer-interface","kind":"build","type":"startup","name":"Neuralink GB-PRIME","url":"https://www.uclh.nhs.uk/news/seven-gb-prime-patients-now-participating-neuralink-trial","one_liner":"UCLH says seven patients received a Neuralink implant between October and December 2025 in an early feasibility study.","problem_slugs":"brain-computer-interface","risk_slugs":"","location":"London","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"synchron-focus-aus-build-brain-computer-interface","kind":"build","type":"startup","name":"Synchron FOCUS-AUS","url":"https://clinicaltrials.gov/study/NCT07533903","one_liner":"ClinicalTrials.gov lists Synchron study NCT07533903 as active, not recruiting, with an estimated enrollment of 10.","problem_slugs":"brain-computer-interface","risk_slugs":"","location":"Melbourne","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"synchron-intent-pause-learn-brain-computer-interface","kind":"learn","type":"report","name":"Citeline on the Synchron pause","url":"https://insights.citeline.com/medtech-insight/business/r-and-d/clinical-trials/synchron-pauses-clinical-trial-on-brain-interface-plans-to-resume-trial-with-upgraded-system-EI6NFVRTHVF3TPIX7NKBDAXLOE/","one_liner":"Citeline, 19 November 2026, says Synchron paused enrollment in the INTENT trial of its second-generation Stentrode after a lead performance issue.","problem_slugs":"brain-computer-interface","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"cdc-als-learn-brain-computer-interface","kind":"learn","type":"government","name":"CDC National ALS Registry fact sheet","url":"https://wwwn.cdc.gov/ALS/Download/Incidence_Prevalence%20Fact%20Sheet.pdf","one_liner":"Last reviewed June 2024: about 30,000 people in the United States are living with ALS, and about 5,000 to 6,000 are diagnosed each year.","problem_slugs":"brain-computer-interface","risk_slugs":"","location":"United States","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"doctronic-utah-build-ai-clinical-care","kind":"build","type":"startup","name":"Doctronic","url":"https://commerce.utah.gov/ai/regulatory-relief-4/authorized-pilots/doctronic/","one_liner":"Utah approved a Doctronic pilot that can process 30, 60, or 90 day renewals of medicines a licensed provider already prescribed.","problem_slugs":"ai-clinical-care","risk_slugs":"","location":"Utah","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"utah-oaip-doctronic-learn-ai-clinical-care","kind":"learn","type":"government","name":"Utah Office of Artificial Intelligence Policy","url":"https://commerce.utah.gov/ai/regulatory-relief-4/authorized-pilots/doctronic/","one_liner":"The Office says the pilot is still in phase 1, a physician must authorize each renewal, and no serious safety incident has been reported to it.","problem_slugs":"ai-clinical-care","risk_slugs":"","location":"Utah","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"nejm-utah-pilot-learn-ai-clinical-care","kind":"learn","type":"paper","name":"NEJM on Utah's renewal pilot","url":"https://www.nejm.org/doi/full/10.1056/NEJMp2601148","one_liner":"Perspective published 18 April 2026 on Utah's pilot of an AI system that renews some prescriptions for chronic conditions.","problem_slugs":"ai-clinical-care","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"who-uhc-learn-ai-clinical-care","kind":"learn","type":"report","name":"WHO universal health coverage fact sheet","url":"https://www.who.int/news-room/fact-sheets/detail/universal-health-coverage-(uhc)","one_liner":"The 5 December 2025 fact sheet says about 4.6 billion people were not fully covered by essential health services in 2023.","problem_slugs":"ai-clinical-care","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"vitara-extend-build-artificial-womb","kind":"build","type":"startup","name":"Vitara Biomedical","url":"https://www.vitara.com/","one_liner":"Vitara describes EXTEND, a fluid-filled system intended for newborns delivered as early as 22 weeks, for up to 28 days.","problem_slugs":"artificial-womb","risk_slugs":"","location":"Philadelphia","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"},{"id":"who-preterm-learn-artificial-womb","kind":"learn","type":"report","name":"WHO preterm birth fact sheet","url":"https://www.who.int/news-room/fact-sheets/detail/preterm-birth","one_liner":"The 10 May 2023 fact sheet says an estimated 13.4 million babies were born preterm in 2020, and about 900,000 children died of preterm complications in 2019.","problem_slugs":"artificial-womb","risk_slugs":"","location":"","amount":"","amount_source_url":"","checked_date":"2026-11-20","checked":true,"license":"CC-BY-4.0"}]}